MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 256 filers reported holding MIRATI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $294,836,470 | +82.4% | 6,768,514 | +51.3% | 6.22% | +102.2% |
| Q2 2023 | $161,608,948 | +19.3% | 4,472,985 | +22.8% | 3.08% | +9.1% |
| Q1 2023 | $135,450,979 | -17.9% | 3,643,114 | 0.0% | 2.82% | -16.3% |
| Q4 2022 | $165,069,495 | +25.5% | 3,643,114 | +93.5% | 3.37% | +11.2% |
| Q3 2022 | $131,485,000 | +4.0% | 1,882,663 | 0.0% | 3.03% | -7.2% |
| Q2 2022 | $126,383,000 | -1.6% | 1,882,663 | +20.6% | 3.26% | +22.9% |
| Q1 2022 | $128,386,000 | -43.9% | 1,561,497 | 0.0% | 2.66% | -20.6% |
| Q4 2021 | $229,056,000 | -13.3% | 1,561,497 | +4.6% | 3.34% | -16.0% |
| Q3 2021 | $264,044,000 | +12.2% | 1,492,532 | +2.4% | 3.98% | +12.1% |
| Q2 2021 | $235,435,000 | +3.1% | 1,457,532 | +9.3% | 3.55% | -0.3% |
| Q1 2021 | $228,383,000 | -1.4% | 1,333,232 | +26.4% | 3.56% | -8.2% |
| Q4 2020 | $231,581,000 | +27.2% | 1,054,364 | -3.8% | 3.88% | -11.3% |
| Q3 2020 | $181,992,000 | +46.5% | 1,096,005 | +0.8% | 4.38% | +25.4% |
| Q2 2020 | $124,186,000 | +64.0% | 1,087,726 | +10.4% | 3.49% | +7.2% |
| Q1 2020 | $75,730,000 | -8.9% | 985,166 | +52.6% | 3.26% | +3.9% |
| Q4 2019 | $83,170,000 | +80.1% | 645,427 | +8.9% | 3.14% | +14.3% |
| Q3 2019 | $46,183,000 | +75.6% | 592,776 | +132.2% | 2.75% | +95.6% |
| Q2 2019 | $26,293,000 | +14.9% | 255,270 | -18.2% | 1.40% | -10.1% |
| Q1 2019 | $22,876,000 | +1291.5% | 312,093 | +705.1% | 1.56% | +920.3% |
| Q4 2018 | $1,644,000 | +166.9% | 38,765 | -70.1% | 0.15% | -34.1% |
| Q4 2016 | $616,000 | -27.9% | 129,697 | +0.4% | 0.23% | -10.1% |
| Q3 2016 | $854,000 | +19.3% | 129,129 | -1.5% | 0.26% | +5.3% |
| Q2 2016 | $716,000 | -92.2% | 131,052 | -69.4% | 0.24% | -92.6% |
| Q1 2016 | $9,169,000 | -24.7% | 428,457 | +11.2% | 3.33% | -17.3% |
| Q4 2015 | $12,180,000 | -26.6% | 385,456 | -20.0% | 4.02% | -22.0% |
| Q3 2015 | $16,593,000 | – | 482,069 | – | 5.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $116,595,216 | 81.37% |
| ORACLE INVESTMENT MANAGEMENT INC | 201,400 | $7,488,052 | 7.25% |
| Paradigm Biocapital Advisors LP | 1,396,779 | $51,932,243 | 4.92% |
| Octagon Capital Advisors LP | 750,000 | $27,885,000 | 4.01% |
| Boxer Capital, LLC | 2,000,000 | $74,360 | 3.65% |
| Artal Group S.A. | 1,537,709 | $57,172 | 3.40% |
| Avoro Capital Advisors LLC | 5,555,555 | $206,555,535 | 3.06% |
| RTW INVESTMENTS, LP | 3,643,114 | $135,450,979 | 2.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 244,000 | $9,071,920 | 2.53% |
| Kynam Capital Management, LP | 499,853 | $18,584,535 | 2.40% |